IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy

INTRODUCTION: IDegLira is a once-daily combination of insulin degludec (IDeg) and liraglutide. Trials directly comparing IDegLira with alternative strategies for intensifying basal insulin are ongoing. While awaiting results, this analysis compared indirectly how different strategies affected glycat...

Descripción completa

Detalles Bibliográficos
Autores principales: Freemantle, Nick, Mamdani, Muhammad, Vilsbøll, Tina, Kongsø, Jens Harald, Kvist, Kajsa, Bain, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674480/
https://www.ncbi.nlm.nih.gov/pubmed/26582052
http://dx.doi.org/10.1007/s13300-015-0142-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674480/
https://www.ncbi.nlm.nih.gov/pubmed/26582052
http://dx.doi.org/10.1007/s13300-015-0142-y

Ejemplares similares